This inventor holds 2 USPTO granted patents. Top assignee: Boehringer Ingelheim Pharma Kg. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Jacobus C A Van Meel: Innovator in Kinase Inhibitory Activity
Introduction
Jacobus C A Van Meel is a notable inventor based in Mittelbiberach, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. With a total of 2 patents, his work has the potential to impact therapeutic strategies in various diseases.
Latest Patents
His latest patents include "Substituted indolinones with kinase inhibitory activity" and "Substituted indolinones of general formula Indolinones having kinase inhibitory activity." These inventions focus on the development of substituted indolinones that exhibit kinase inhibitory properties, which are crucial for the treatment of various conditions.
Career Highlights
Jacobus C A Van Meel is currently employed at Boehringer Ingelheim Pharma KG, a leading global pharmaceutical company. His role involves extensive research and development in the field of drug discovery, where he applies his expertise to create innovative solutions for unmet medical needs.
Collaborations
Throughout his career, he has collaborated with esteemed colleagues such as Rainer Walter and Armin Heckel. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Jacobus C A Van Meel is a prominent figure in the field of kinase inhibitors, with a focus on developing innovative therapeutic agents. His contributions to medicinal chemistry and collaboration with other experts highlight his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile